Galmed Pharmaceuticals LTD (GLMD) Stake Has Lifted by 683 Capital Management Llc; As General Mo(Gm) (GM) Stock Declined, Psagot Investment House LTD Lifted Position by $1.02 Million

January 14, 2018 - By Adrian Erickson

Psagot Investment House Ltd increased its stake in General Mo(Gm) (GM) by 51.43% based on its latest 2017Q3 regulatory filing with the SEC. Psagot Investment House Ltd bought 25,375 shares as the company’s stock declined 12.09% while stock markets rallied. The institutional investor held 74,715 shares of the auto manufacturing company at the end of 2017Q3, valued at $3.02M, up from 49,340 at the end of the previous reported quarter. Psagot Investment House Ltd who had been investing in General Mo(Gm) for a number of months, seems to be bullish on the $62.60B market cap company. The stock decreased 0.27% or $0.12 during the last trading session, reaching $44.07. About 14.91 million shares traded or 16.74% up from the average. General Motors Company (NYSE:GM) has risen 7.92% since January 14, 2017 and is uptrending. It has underperformed by 8.78% the S&P500.

683 Capital Management Llc increased its stake in Galmed Pharmaceuticals Ltd (GLMD) by 9.86% based on its latest 2017Q3 regulatory filing with the SEC. 683 Capital Management Llc bought 49,295 shares as the company’s stock rose 17.66% with the market. The hedge fund held 549,295 shares of the major pharmaceuticals company at the end of 2017Q3, valued at $5.02 million, up from 500,000 at the end of the previous reported quarter. 683 Capital Management Llc who had been investing in Galmed Pharmaceuticals Ltd for a number of months, seems to be bullish on the $140.96M market cap company. The stock decreased 0.63% or $0.07 during the last trading session, reaching $11.07. About 34,068 shares traded. Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD) has risen 0.41% since January 14, 2017 and is uptrending. It has underperformed by 16.29% the S&P500.

Among 5 analysts covering Galmed Pharmaceuticals Ltd (NASDAQ:GLMD), 5 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Galmed Pharmaceuticals Ltd had 7 analyst reports since August 14, 2015 according to SRatingsIntel. On Monday, July 31 the stock rating was maintained by Maxim Group with “Buy”. The firm earned “Buy” rating on Thursday, August 13 by Roth Capital. The firm has “Buy” rating given on Monday, March 28 by H.C. Wainwright. The stock has “Buy” rating by H.C. Wainwright on Tuesday, August 8.

683 Capital Management Llc, which manages about $566.08M and $951.63 million US Long portfolio, decreased its stake in Peabody Energy Corp New by 116,960 shares to 269,400 shares, valued at $7.82 million in 2017Q3, according to the filing. It also reduced its holding in Echostar Corp (NASDAQ:SATS) by 19,471 shares in the quarter, leaving it with 129,926 shares, and cut its stake in Durect Corp (NASDAQ:DRRX).

Among 29 analysts covering General Motors Company (NYSE:GM), 16 have Buy rating, 3 Sell and 10 Hold. Therefore 55% are positive. General Motors Company had 81 analyst reports since July 24, 2015 according to SRatingsIntel. On Tuesday, August 9 the stock rating was initiated by Seaport Global with “Buy”. The stock of General Motors Company (NYSE:GM) earned “Hold” rating by Nomura on Wednesday, November 1. Morgan Stanley reinitiated the stock with “Underweight” rating in Monday, August 24 report. Craig Hallum maintained General Motors Company (NYSE:GM) rating on Wednesday, October 25. Craig Hallum has “Hold” rating and $45.0 target. The firm has “Overweight” rating by Morgan Stanley given on Thursday, September 21. The rating was maintained by RBC Capital Markets on Tuesday, July 25 with “Hold”. The rating was upgraded by Vetr on Tuesday, August 11 to “Hold”. The firm has “Hold” rating by Standpoint Research given on Thursday, September 14. Citigroup maintained the shares of GM in report on Wednesday, September 2 with “Buy” rating. The stock of General Motors Company (NYSE:GM) earned “Market Perform” rating by BMO Capital Markets on Wednesday, October 25.

Psagot Investment House Ltd, which manages about $2.37 billion US Long portfolio, decreased its stake in Spdr (Spy) (SPY) by 2,584 shares to 350,197 shares, valued at $87.98M in 2017Q3, according to the filing. It also reduced its holding in Ishare Mexi(Eww (EWW) by 63,906 shares in the quarter, leaving it with 789,049 shares, and cut its stake in Spdr S&P P(Xph) (XPH).

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.